Evidence for dystonia reduction in cerebral palsy remains limited
- PMID: 38640101
- PMCID: PMC11579803
- DOI: 10.1111/dmcn.15923
Evidence for dystonia reduction in cerebral palsy remains limited
Abstract
This commentary is on the clinical practice guideline by Fehlings et al. on pages
References
-
- Fehlings D, Brown L, Harvey A, Himmelmann K, Lin J‐P, Macintosh A, et al. Pharmacological and neurosurgical interventions for managing dystonia in cerebral palsy: a systematic review. Dev Med Child Neurol. 2018; 60: 356–366. - PubMed
-
- Lumsden DE, Crowe B, Basu A, Amin S, Devlin A, DeAlwis Y, et al. Pharmacological management of abnormal tone and movement in cerebral palsy. Arch Dis Child. 2019; 104: 775–780. - PubMed
-
- Harvey A, Reddihough D, Scheinberg A, Williams K. Oral medication prescription practices of tertiary‐based specialists for dystonia in children with cerebral palsy. J Paediatr Child Health. 2018; 54: 401–404. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
